CompletedPhase 3NCT02067910

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome

Studying Primary Sjögren disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Medical Center Groningen
Principal Investigator
H. Bootsma, MD, PhD
University Medical Center Groningen
Intervention
Abatacept SC(drug)
Enrollment
80 target
Eligibility
18 years · All sexes
Timeline
20142019

Study locations (1)

Collaborators

Bristol-Myers Squibb

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02067910 on ClinicalTrials.gov

Other trials for Primary Sjögren disease

Additional recruiting or active studies for the same condition.

See all trials for Primary Sjögren disease

← Back to all trials